Flotetuzumab
Monoclonal antibody | |
---|---|
Type | Di-single-chain variable fragment |
Source | Humanized (from mouse) |
Target | interleukin 3 receptor |
Clinical data | |
Synonyms | MGD006 |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C2618H4040N704O813S16 |
Molar mass | 58.9 g/mol |
Flotetuzumab (MGD006) (INN[1]) is a humanized antibody fragment designed for the treatment of hematologic malignancies.
This drug is being developed by MacroGenics, Inc.[2]
References
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.